A 60YearOld Woman With Generalized Weakness and Stiff Knees Chapter 21 - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

A 60YearOld Woman With Generalized Weakness and Stiff Knees Chapter 21

Description:

Tophaceous gout. M F. 25-70 M. 95 percent RF ... Pseudogout vs Gout. Malar rash and Oral mucositis. Systemic lupus erythematosus ... – PowerPoint PPT presentation

Number of Views:109
Avg rating:3.0/5.0
Slides: 33
Provided by: eugeneg
Category:

less

Transcript and Presenter's Notes

Title: A 60YearOld Woman With Generalized Weakness and Stiff Knees Chapter 21


1
A 60-Year-Old Woman With Generalized Weakness and
Stiff Knees Chapter 21
Daphne Ang, M.D. Pathology Resident Eugene G.
Martin, Ph.D. Associate Professor of Pathology
Laboratory Medicine
  • Based upon LABORATORY MEDICINE CASEBOOK. An
    introduction to clinical reasoning
  • Jana Raskova, MD Professor of Pathology
    Laboratory MedicineStephen Shea, MD
    Professor of Pathology Laboratory
    MedicineFrederick Skvara, MD Associate
    Professor of Pathology Laboratory MedicineNagy
    Mikhail, MD Assistant Professor of Pathology
    Laboratory MedicineUMDNJ-Robert Wood Johnson
    Medical SchoolPiscataway, NJ

2
History and Presentation
  • A 60-year-old woman admitted to hospital with
    complaints of
  • Generalized weakness of two weeks duration
  • Morning stiffness of both knees aggravated by
    movement
  • Mild fever
  • Ten pound weight loss in previous month
  • Two similar episodes reported in the previous
    year involving joints of wrist and hands
    responded to anti-inflammatory medications
  • She has been taking aspirin to relieve the pain
  • Physical Exam
  • Alert ?, mild distress
  • Temp. 100 oF
  • BP 120/80
  • HR 85 bpm and regular
  • Respiratory rate 20 per minute
  • Abdomen soft with mild splenomegaly
  • Knees swollen, warm and painful.
  • Mild atrophy of the muscles of the forearm
  • Small subcutaneous nodues in the back of the
    forearms
  • Swelling noted metacarpal-phalangeal joints

Whats In Your Differential? What Do You Do
Next?
3
Distinction between rheumatoid arthritis and
osteoarthritis
4
Differential Diagnosis
5
Differential Diagnosis
6
Scleroderma
Malar rash and Oral mucositis Systemic lupus
erythematosus
Pseudogout vs Gout
7
Gottrons papule
Podagra - Gout
Uveitis, Urethritis, Arthritis Reiters syndrome
8
HEMATOLOGY
9
Erythrocyte Sedimentation Rate
  • PRINCIPLE The distance the erythrocytes will
    fall is a function of weight, surface area and
    charge
  • Erythrocytes have a negative potential charge
    (the zeta potential) which normally repels rbcs
  • Plasma proteins have a positive charge and
    promote erythrocyte aggregation. particularly
    fibrinogen
  • LIMITATIONS OF TEST
  • Very non-specific
  • Sometimes normal where usually it is abnormal
  • Very technique specific eg tilt of the tube is
    CRITICAL. Must be perfectly vertical.
  • ESR falsely elevated in
  • Anemia
  • Macrocytosis
  • Concentration of anti-coagulant too high
  • ESR falsely reduced in
  • Polycythemia
  • Microcytosis
  • Marked poikilocytosis (sickle cells,
    acanthocytes)
  • Any delay in running the test (rbcs become less
    spherical and less readily form a rouleaux

10
Erythrocyte Sedimentation Rate (2)
  • Conditions resulting in increased ESR
  • Acute or chronic infection
  • Tissue necrosis and/or infarction
  • Well-established malignancy
  • Rheumatoid-collagen diseases
  • Temporal arteritis
  • Polymyalgia rheumatica
  • Rheumatoid arthritis
  • Collagen disease
  • Abnormal serum proteins
  • Changes in serum proteins that alter plasma
    viscosity influence RBC sedimentation eg.
    Myeloma proteins
  • Physiologic stress pregnancy obesity chronic
    renal failure (75)
  • MARKED ELEVATIONS IN ESR (100mm/hour)
  • Multiple myeloma
  • macroglobulinemia
  • polyclonal hypergammaglobulinemia
  • hyperfibrinogenemia
  • PROGNOSTIC in Hodgkins
  • Poor - ESR 60 mm/hour in asymptomatic Hodgkins
    patient (as bad as a symptomatic patient)

11
Erythrocyte Sedimentation Rate (3)
  • 3 main uses
  • As an aid in detecting an inflammatory process
  • As a monitor of disease course or activity
  • As a screen for occult inflammatory or neoplastic
    conditions

12
C-Reactive Protein
  • Produced by the liver - present during episodes
    of acute inflammation.
  • Elevations in
  • Rheumatoid arthritis
  • Rheumatic fever
  • Cancer
  • Tuberculosis
  • Pneumococcal pneumonia
  • Myocardial infarction
  • SLE
  • Connective tissue disease
  • Bacterial, viral, fungal, or parastic infection
  • Other causes of ongoing inflammation
  • Positive CRP results also occur during the last
    half of pregnancy or with the use of oral
    contraceptives

Acute Phase Reactants Plasma proteins elevated
acutely in reponse to illness, infection, trauma,
tissue necrosis cerulplasmin, haptoglobin,
fibrinogen, CRP, a-1 antitrypsin
13
CHEMISTRY
14
Rheumatoid Arthritis Lab Studies
  • Anemia in approximately 80 of patients with RA.
    The anemia is normocytic and normochromic.
  • Thrombocytosis may be present.
  • Erythrocyte sedimentation rate (ESR) is elevated
    in approximately 90 of patients with RA.
  • Serum RF result is positive in approximately 70
    of patients with RA.
  • Antinuclear antibodies (ANA) are present in
    approximately 30 of patients with RA.
  • Can identify autoantibodies against DNA, histones
    or soluble nuclear antigens
  • Felty syndrome is a triad of RA, neutropenia, and
    splenomegaly. Patients with Felty syndrome are
    prone to serious bacterial infections that result
    in higher rates of morbidity and mortality than
    for other patients with RA. This requires prompt
    diagnosis and initiation of antibiotic therapy

15
Hypoalbuminemia
  • Causes of decreased plasma albumin
  • Decreased synthesis.
  • Increased catabolism very slow
  • Increased loss
  • Nephrotic syndrome
  • Exudative loss in burns
  • Haemorrhage
  • Gut loss
  • Redistribution
  • Haemodilution
  • Increased capillary permeability (leakage into
    the interstitium)
  • Decreased lymph clearance.
  • Stress response
  • Overall, the picture in the stress response is
  • Initial decrease in albumin associated with
    increase in acute phase proteins.
  • Subsequent global increase in hepatic protein
    synthesis including albumin.

16
Patient Summary
  • Hematology
  • Anemia normochromic, normocytic
  • Thrombocytosis
  • Slightly elevated WBC
  • Increased ESR
  • Chemistry
  • Uric Acid is a little low
  • Albumin is a little low
  • Cholesterol is a little high

17
Immunology Tests
Rheumatoid Factor (RF) usually an IgM
auto-antibody to IgG. Occasionally the antibody
is against IgA or IgE. Produced by activated B
cells and forms an immune complex by binding to
the Fc fraction of IgG molecules.
18
Rheumatoid Arthritis
  • DESCRIPTION
  • Chronic, systemic inflammatory disorder effecting
    many tissues and organs principally joints
  • Cause unknown, but autoimmunity plays a pivotal
    role
  • 1 of the worlds population
  • PATHOGENESIS
  • RA is triggered by exposure to an arthritogenic
    microbial antigen ? acute arthritis FOLLOWED by a
    runaway autoimmune reaction
  • Four elements
  • Genetic susceptibility
  • Concordance monozygotic twins
  • 70 are HLA-DR4
  • Microbial antigens
  • Autoimmunity
  • Mediators of joint damage (cytokines, IL, TNF,
    proteases, elastases, etc.
  • MORPHOLOGY
  • Joints
  • Perivascular inflammatory infiltrate
  • Increased vascularity
  • Organizing fibrin
  • Osteoclastic acitivity ?Juxta-articular erosions
  • Subchondral cysts
  • Osteoporosis
  • Skin
  • Rheumatoid nodules (25 of patients) at areas
    subject to pressure (elbows, lumbosacral)
  • Blood Vessels
  • Complication of severe RA
  • Vasculitic syndromes potentially catastrophic
  • Medium Small arteries
  • Similar to Polyarteritis Nodosa EXCEPT kidneys
    ARE NOT involved
  • Peripheral neuropathy, ulcers and gangrene

19
  • Ulnar deviation of fingers
  • Periarticular osteoporosis clearing at the ends
    of the bones
  • Phalangeal-metacarpal joints are destroyed with
    resultant joint narrowing

20
Joint aspiration Papanicolaou stain. Mag x78.
  • Knee joint aspirate
  • Predominant cells -neutrophils, but scattered
    macrophages also present
  • Early involvement associated with neutrophil rich
    aspirate

21
Rheumatoid Arthritis
  • Joint capsule - lined with synovium, ? produces
    synovial fluid that lubricates and nourishes
    joint tissues.
  • In rheumatoid arthritis, the synovium becomes
    inflamed, causing warmth, redness, swelling, and
    pain.
  • The inflamed synovium invades and damages the
    cartilage and bone of the joint.
  • Rheumatoid arthritis also can cause more
    generalized bone loss that may lead to
    osteoporosis

http//www.niams.nih.gov/hi/topics/arthritis/rahan
dout.htm
22
Features of Rheumatoid Arthritis
  • Onset 20-45
  • Females males (31)
  • Tender, warm, swollen joints
  • Symmetrical pattern of affected joints
  • Joint inflammation
  • Primary - the wrist and finger joints closest to
    the hand
  • Secondary - sometimes g other joints, including
    the neck, shoulders, elbows, hips, knees, ankles,
    and feet
  • Fatigue, occasional fevers, a general sense of
    not feeling well
  • Pain and stiffness lasting for more than 30
    minutes in the morning or after a long rest

23
Rheumatoid Arthritis
  • Onset 20-45
  • Females males (31)
  • Associated laboratory findings
  • Anemia.
  • Osteoporosis
  • Particularly if using corticosteroid drugs, such
    as prednisone.
  • Sjogrens syndrome
  • Systemic inflammatory disorder that affects the
    mucous membranes
  • causing dry mouth,
  • decreased tear production, and other dry
    conditions of the bodys membranes.
  • Felty syndrome
  • Felty's Syndrome
  • Rheumatoid arthritis, Splenomegaly, Leucopoenia
    (weight loss, skin pigmentation and ulceration,
    lymphadenopathy and anaemia)

24
Normal synovial lining HE x78
Synovial Lining
  • Lining epithelium is thin and lies on top of a
    loose connective tissue layer.
  • Scattered lymphocytes and plasma cells are present

Loose connective tissue
25
Portion of synovium from patient. HE x 12.
  • Synovial villi are thickened with a heavy
    inflammatory cell infiltrate and increased
    vascularity (granulation tissue)
  • Superficial areas of necrosis are present and
    masses of inflammatory cells can be seen free
    above the synovial surface

26
Portion of synovium from patient. HE x78.
  • Neutrophils, lymphocytes, plasma cells,
    macrophages, and fibroblasts are responsible for
    increased cellularity.
  • Capillaries are increased in number, synovial
    lining cells are hypertophic and hyperplastic.

Hyperplastic, hypertrophic synovial lining cells
27
Material from subcutaneous nodules Unstained
DIC microscopy. Orig. mag x150
  • Numerous flat, notched plates consistent with a
    cholesterol crystals.
  • Common in rheumatoid nodules
  • Not generally found in joint aspirates

28
Subcutaneous nodules in rheumatoid arthritis. HE
x20.
  • 20-30 of patients with rheumatoid arthritis have
    rheumatoid nodules
  • Most common pressure areas such as elbow
  • Other locations
  • Lung, spleen, myocardium, cardiac valves,
    pericardium and aorta.
  • Eosinophilic center of fibrinoid necrosis
    surrounded by palisading histocytes.
  • Note inflammatory cell infiltrate of lymphocytes
    and plasma cells, as well as some fibrosis.

29
Case Summary
  • Final Diagnosis
  • Active rheumatoid arthritis
  • Symmetrical joint pain, swelling and morning
    stiffness typically

30
Sequelae of Rheumatoid Arthritis
  • Higher risk of coronary heart disease
  • More silent heart attacks (5X ?) and sudden
    cardiac deaths (3X ?)
  • Not explained by risk factors such as elevated
    cholesterol, blood pressure and body mass index,
    diabetes, and/or alcohol abuse

31
American Rheumatism Association revised criteria
for rheumatoid arthritis classification
32
Therapeutic Options
  • Patient education and counseling
  • Pharmacologic treatment
  • Analgesics, NSAIDS
  • Glucocorticoids, SAARDS/MARDS (slow-acting
    antirheumatic drugs disease-modifying
    antirheumatic drugs)
  • Surgery for functional abnormalities caused by
    proliferative synovitis (eg. Tendon rupture) or
    by bone and joint destruction
Write a Comment
User Comments (0)
About PowerShow.com